Sponsor:
University of Michigan
Code:
NCT05505500
Conditions
Fluid Overload
Glomerulosclerosis, Focal Segmental
Edema
Membranous Nephropathy
Minimal Change Disease
Eligibility Criteria
Sex: All
Age: 2+
Healthy Volunteers: Not accepted
Interventions
Interview
Brief summary:
Conditions
Fluid Overload
Glomerulosclerosis, Focal Segmental
Edema
Membranous Nephropathy
Minimal Change Disease
Study ID
NCT05505500
Start date
Apr 18, 2022
Status verified date
Nov, 2025
Completion date
Apr 30, 2026
Anticipated
Primary completion date
Apr 30, 2026
Anticipated
Eligibility Criteria
Sex: All
Age: 2+
Healthy Volunteers: Not accepted
Enrollment
150 participants
Anticipated
Arms
Parent/Guardian of child with Nephrotic Syndrome (NS)
Person with Nephrotic Syndrome (NS)
Interventions
Interview
Primary outcome measure
Central contacts
Locations
University of Michigan
Recruiting
Ann Arbor, Michigan, United States, 48109
Contacts
Principal Investigator:
Eloise Salmon, M.D.
Sponsor
University of Michigan
Last update posted
Dec 22, 2025
Last verified
Nov, 2025
Keywords
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-09. This information was provided to ClinicalTrials.gov by University of Michigan on 2025-12-22.